Genome-wide CRISPR-Cas9 screening identifies ITGA8 responsible for abivertinib sensitivity in lung adenocarcinoma.
Li XG, Zhu GS, Cao PJ, Huang H, Chen YH, Chen C, Chen PJ, Wu D, Ding C, Zhang ZH, Zhang RH, Hu ZX, Zhao WH, Liu MH, Li YW, Liu HY, Chen J.
Li XG, et al. Among authors: cao pj.
Acta Pharmacol Sin. 2025 Jan 14. doi: 10.1038/s41401-024-01451-0. Online ahead of print.
Acta Pharmacol Sin. 2025.
PMID: 39809840